Transgenic mice overexpressing glycerol 3‐phosphate dehydrogenase and carrying ALBP promoter/enhancer‐reporter constructs were generated to study obesity mechanisms. Additionally, transgenic and gene knockout mice were used to identify mutations causing single‐gene obesity syndromes and for pharmaceutical drug development targeting human‐specific drug pathways. The gene discussed is FABP4; the disease is Obesity.